Biogen Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€114.05
Target price
01.08.26
€191.89
Performance (%)
4.21%
Price
22.08.25
€118.85
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 4.21%. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | 0.295% |
| iShares Core DAX® | -0.099% |
| iShares Nasdaq 100 | -1.085% |
| iShares Nikkei 225® | -0.835% |
| iShares S&P 500 | 0.099% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $208.00 to $219.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat